πŸ‡ΊπŸ‡Έ FDA
Patent

US 7060824

Pyrrolotriazolopyrimidinone derivatives

granted A61PA61P1/00A61P11/00

Quick answer

US patent 7060824 (Pyrrolotriazolopyrimidinone derivatives) held by Almirall Prodesfarma S.A. expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Almirall Prodesfarma S.A.
Grant date
Tue Jun 13 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P1/00, A61P11/00, A61P11/02, A61P11/06